Xylocor Therapeutics, Inc.

ACTIVE

宾夕法尼亚州韦恩县, Pennsylvania, United Stateswww.xylocor.comHolding1–10 employeesEstablished: 2013-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2013

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

50.0%

Trial Status Distribution

Active, not recruiting

25.0%

Completed

25.0%

Not yet recruiting

25.0%

Recruiting

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG

Phase 2

Not yet recruiting

interventional

Aug 2025116 participants

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

Phase 2

Recruiting

interventional

Jul 2025106 participants

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial): A Phase 1/2 Multi-Center, Open-Label Study to Evaluate Safety, Tolerability and Efficacy

Phase 1

Active, not recruiting

Sep 202144 participants

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)

Phase 1

Completed

interventional

Jan 202041 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations